摘要
乳腺癌围手术期中医药参与治疗的研究还处于起步阶段。随着乳腺癌的生物学特性不断明了,其治疗观念发生了转变,如手术范围有缩小的趋势、术中可能采用一次性大剂量放射治疗以及术后早期的辅助化疗等,使得围手术期干预因素有所变化。本文就中医药参与乳腺癌围手术期治疗的有关问题进行探讨,以便使其日臻规范并发挥更有效的作用。
The study on use of traditional Chinese medicine in perioperative management of breast cancer is still in the beginning phase. With the emergence of new understanding about the biological characteristics of breast cancer, the concept of treatment has changed. For instance, the resection extent is tending to be narrower, large doses of radiotherapy may be adopted during the operation, and early use of adjuvant chemotherapy is advocated after the operation. These have bought about changes to the intervention factors in the perioperative period for breast cancer. Some related problems about the participation of traditional Chinese medicine in perioperative management of breast cancer are discussed in this article, so as to make the perioperative management perfect.
出处
《中西医结合学报》
CAS
2005年第3期178-180,共3页
Journal of Chinese Integrative Medicine
关键词
乳腺癌
围手术期
中西医结合疗法
辨证论治
breast cancer perioperative period integrated Chinese-Western therapy
